Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 19/20 | 0.75 |
| ▸ | LPAR2 | Q9HBW0 | 15/20 | 0.75 |
| ▸ | LPAR1 | Q92633 | 13/20 | 0.61 |
| ▸ | LPAR6 | P43657 | 5/20 | 0.50 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.50 |
| ▸ | LPAR5 | Q9H1C0 | 5/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8657668 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL40048 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL8467562 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL8467950 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL7256485 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL8658599 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL6692742 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL2151049 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL1971188 | 1.00 | LPAR3 (0.75) | LPAR3LPAR2LPAR1LPAR6LPAR4 | |
| SCHEMBL14053589 | 0.98 | LPAR3 (0.72) | LPAR3LPAR2LPAR1LPAR6LPAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107434832-B | Polypropylene catalyst component, preparation method and catalyst thereof | 中国石油天然气股份有限公司 | 2020-02-14 | — | — | CN | claimed |
| EP-1825913-B1 | New catalyst systems and their application for metathesis reactions | LANXESS DEUTSCHLAND GMBH (DE) | 2016-08-17 | — | — | EP | claimed |
| US-20110077360-A1 | PROCESS FOR REACTING CHEMICAL COMPOUNDS IN THE PRESENCE OF CATALYST SYSTEMS | LANXESS DEUTSCHLAND GMBH (DE) | 2011-03-31 | — | — | US | claimed |
| US-20070208206-A1 | Novel catalyst systems and a process for reacting chemical compounds in the presence of said catalyst systems | LANXESS DEUTSCHLAND GMBH (DE) | 2007-09-06 | — | — | US | claimed |
| EP-1825913-A1 | New catalyst systems and their application for metathesis reactions | Lanxess Deutschland GmbH & Co.KG (DE) | 2007-08-29 | — | — | EP | claimed |
| CN-101024200-A | Novel catalyst systems and their use for metathesis reactions | LANXESS DEUTSCHLAND GMBH (DE) | 2007-08-29 | — | — | CN | claimed |
| CN-1170893-C | Latent coating for metal surface repair | 3M | 2004-10-13 | — | — | CN | claimed |
| EP-1062283-B1 | LATENT COATING FOR METAL SURFACE REPAIR | MINNESOTA MINING & MFG (US) | 2003-08-27 | — | — | EP | claimed |
| US-20020062894-A1 | Tire can be used in an uninflated condition, such as after being punctured | MINER JENNIFER ANN (US) | 2002-05-30 | — | — | US | claimed |
| US-6331203-B2 | COMPRISING A PIGMENT, A WATER-SOLUBLE ORGANIC SOLVENT, WATER, XANTHANE GUM OF 0.01 TO ABOUT 0.2 WT. % AND AN IONIC POLYSACCHARIDE OTHER THAN XANTHANE GUM; STABILITY | KOTOBUKI & CO., LTD. (JP) | 2001-12-18 | — | — | US | claimed |
| US-20010023651-A1 | Aqueous ink composition for ball-point pen | HATTORI KATSUYA (JP) | 2001-09-27 | — | — | US | claimed |
| US-6275816-B1 | A PIGMENT, A WATER SOLUBLE ORGANIC SOLVENT, WATER, XANTHANE GUM, AND SODIUM ALGINATE; STABLE OVER TIME AND HIGH PIGMENT DISPERSION STABILITY | KOTOBUKI & CO., LTD (JP) | 2001-08-14 | — | — | US | claimed |
| CN-1286720-A | Latent coating for metal surface repair | MINNESOTA MINING & MFG (US) | 2001-03-07 | — | — | CN | claimed |
| EP-1062283-A1 | LATENT COATING FOR METAL SURFACE REPAIR | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2000-12-27 | — | — | EP | claimed |
| US-6075072-A | CONTAINS FRANGIBLE MICROCAPSULES WHICH RUPTURE AND RELEASE FLUID UPON IMPACT OR STRESS LIKELY TO DAMAGE COATING; FLUID FROM MICROCAPSULES CONTAINS FILM FORMING COMPONENT TO COVER THE DAMAGED AREA OF THE COATING AND A CORROSION INHIBITOR | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-06-13 | — | — | US | claimed |
| WO-1999046338-A1 | LATENT COATING FOR METAL SURFACE REPAIR | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-09-16 | — | — | WO | claimed |
| US-20250101337-A1 | LUBRICATING OIL COMPOSITION | CHEVRON JAPAN LTD. (JP) | 2025-03-27 | — | — | US | disclosed |
| EP-4469542-A1 | LUBRICATING OIL COMPOSITION | Chevron Japan Ltd. (JP) | 2024-12-04 | — | — | EP | disclosed |
| US-4233182-A | High activity catalyst for the polymerization of alpha-olefins | STANDARD OIL COMPANY (INDIANA) (US) | 1980-11-11 | — | — | US | disclosed |
| EP-0013744-A1 | Catalyst and process for the polymerization of alpha-olefins and a process for preparing an alpha-olefin polymerization catalyst component | Standard Oil Company (US) | 1980-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208206-A1 | Novel catalyst systems and a process for reacting chemical compounds in the presence of said catalyst systems | NBAS, NNMT, CAT | LPAR3 4529/4885LPAR2 4545/4885LPAR1 4343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.